Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Diabetes Care ; 41(11): 2346-2352, 2018 11.
Article in English | MEDLINE | ID: mdl-30213882

ABSTRACT

OBJECTIVE: Healthy pancreatic ß-cells secrete the hormones insulin and amylin in a fixed ratio. Both hormones are lacking in type 1 diabetes, and postprandial glucose control using insulin therapy alone is difficult. This study tested the pharmacodynamic effects of the amylin analog pramlintide and insulin delivered in a fixed ratio over a 24-h period. RESEARCH DESIGN AND METHODS: Patients with type 1 diabetes were stabilized on insulin pump therapy with insulin lispro before a randomized, single-masked, two-way crossover, 24-h inpatient study in which regular human insulin was administered with pramlintide or placebo using separate infusion pumps in a fixed ratio (9 µg/unit). Meal content and timing and patient-specific insulin doses were the same with each treatment. The primary outcome measure was change in mean glucose by continuous glucose monitoring (CGM). Profiles of laboratory-measured glucose, insulin, glucagon, and triglycerides were also compared. RESULTS: Mean 24-h glucose measured by CGM was lower with pramlintide versus placebo (8.5 vs. 9.7 mmol/L, respectively; P = 0.012) due to a marked reduction of postprandial increments. Glycemic variability was reduced, and postprandial glucagon and triglycerides were also lower with pramlintide versus placebo. Gastrointestinal side effects were more frequent during use of pramlintide; no major hypoglycemic events occurred with pramlintide or placebo. CONCLUSIONS: Coadministration of fixed-ratio pramlintide and regular human insulin for 24 h improved postprandial hyperglycemia and glycemic variability in patients with type 1 diabetes. Longer studies including dose titration under daily conditions are needed to determine whether this regimen could provide long-term improvement of glycemic control.


Subject(s)
Diabetes Mellitus, Type 1/drug therapy , Hyperglycemia/prevention & control , Hypoglycemic Agents/administration & dosage , Insulin, Regular, Human/administration & dosage , Islet Amyloid Polypeptide/administration & dosage , Adolescent , Adult , Aged , Blood Glucose/drug effects , Blood Glucose/metabolism , Blood Glucose Self-Monitoring , Cross-Over Studies , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/complications , Drug Administration Schedule , Drug Combinations , Female , Humans , Hyperglycemia/blood , Hypoglycemic Agents/adverse effects , Insulin Infusion Systems , Insulin, Regular, Human/adverse effects , Islet Amyloid Polypeptide/adverse effects , Male , Meals , Middle Aged , Single-Blind Method , Young Adult
3.
Diabetes Care ; 35(4): 706-10, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22357189

ABSTRACT

OBJECTIVE: To improve glucose sensor accuracy in subjects with type 1 diabetes by using multiple sensors and to assess whether the benefit of redundancy is affected by intersensor distance. RESEARCH DESIGN AND METHODS: Nineteen adults with type 1 diabetes wore four Dexcom SEVEN PLUS subcutaneous glucose sensors during two 9-h studies. One pair of sensors was worn on each side of the abdomen, with each sensor pair placed at a predetermined distance apart and 20 cm away from the opposite pair. Arterialized venous blood glucose levels were measured every 15 min, and sensor glucose values were recorded every 5 min. Sensors were calibrated once at the beginning of the study. RESULTS: The use of four sensors significantly reduced very large errors compared with one sensor (0.4 vs. 2.6% of errors ≥50% from reference glucose, P < 0.001) and also improved overall accuracy (mean absolute relative difference, 11.6 vs. 14.8%, P < 0.001). Using only two sensors also significantly improved very large errors and accuracy. Intersensor distance did not affect the function of sensor pairs. CONCLUSIONS: Sensor accuracy is significantly improved with the use of multiple sensors compared with the use of a single sensor. The benefit of redundancy is present even when sensors are positioned very closely together (7 mm). These findings are relevant to the design of an artificial pancreas device.


Subject(s)
Biosensing Techniques/instrumentation , Blood Glucose/analysis , Diabetes Mellitus, Type 1/blood , Abdomen , Adult , Biosensing Techniques/standards , Blood Glucose Self-Monitoring/instrumentation , Blood Glucose Self-Monitoring/standards , Calibration , Diabetes Mellitus, Type 1/therapy , Equipment Design , Equipment Failure Analysis/methods , Female , Humans , Male , Reference Values , Research Design , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...